The goal of this clinician scientist career development award is to facilitate my transition into an independent clinician-scientist with advanced knowledge and capacity with a niche addressing the critical role of matricellular interactions on pathologic remodeling of arteries. My training program comprises a mentored research plan with guidance from an integrated mentoring team with a mentor, Hanjoong Jo, PhD;two co- mentors: Allan Kirk MD, PhD;Bob Taylor MD, PhD;and two external advisors: Don Giddens, PhD (Georgia Institute of Technology);Scott Berceli, MD, PhD (University of Florida). Stiffened arteries independently increase patient mortality, and arterial stiffness initiates and accelerates the development of atherosclerosis. As a clinically active vascular surgeon with a PhD in cell biology, I have identified the development of treatment strategies for arterial stiffness as a significant clinical need for my patients. I have recently identified that disturbed flow promotes arterial stiffening in healthy mice. Preliminary data has identified thrombospondin-1 (THBS-1) as a clinically modifiable target of arterial stiffening in response to disturbed flow. This proposal determines the role of THBS-1 in arterial stiffness. My central hypothesis is that disturbed flow increases EC expression of THBS-1, which promotes arterial stiffness via TGF-? dependent and independent pathways. This project will identify and test the molecular mechanisms involved in arterial stiffness with sophisticated in vitro and in vivo models of disturbed flow. I ill focus this work on identifying the endothelial cell response to disturbed flow and the subsequent changes in vascular wall biology that lead to arterial stiffening utilizing cutting edge techniques with gain and loss of function testing. Importantly the pathways identified will be strategically inhibited to decrease arterial stiffening. This work will provide the protected time and resources necessary to generate important scientific contributions in this field and build my translational research laboratory for a sustainable career in patient-directed scientific investigation.

Public Health Relevance

Arterial stiffness is a modifiable intermediary step in the initiation and progression of atherosclerosis. The biological and physiological cause of arterial stiffness and the signaling mechanisms involved are not well understood. I have demonstrated a novel role for disturbed flow on arterial stiffness and have preliminary evidence supporting the role of thrombospondin-1 (THBS-1) in this process. This clinician scientist career development proposal aims to identify and test in vitro and in vivo the molecular targets controlled by THBS-1 that lead to arterial stiffness. The protected time and mentorship availed to me by this award will develop my scientific skills in and knowledge of biomechanics and advanced molecular techniques to develop and integrate sophisticated biomechanical models of disturbed flow for testing key components of matricellular interactions in arterial stiffening.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08HL119592-01A1
Application #
8700928
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F2))
Program Officer
Wang, Wayne C
Project Start
2014-04-01
Project End
2019-01-31
Budget Start
2014-04-01
Budget End
2015-01-31
Support Year
1
Fiscal Year
2014
Total Cost
$103,560
Indirect Cost
$7,671
Name
Emory University
Department
Surgery
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Arya, Shipra; Khakharia, Anjali; Binney, Zachary O et al. (2018) Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease. Circulation 137:1435-1446
Arya, Shipra; Binney, Zachary O; Khakharia, Anjali et al. (2018) High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg 67:217-228.e1
Chadid, Tatiana; Morris, Andrew; Surowiec, Alexandra et al. (2018) Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients. J Vasc Surg 68:137S-151S.e2
Morris, Andrew D; Dalal, Sidd; Li, Haiyan et al. (2018) Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures. Surgery 163:870-876
Breed, Elise R; Hilliard, Carolyn A; Yoseph, Benyam et al. (2018) The small heat shock protein HSPB1 protects mice from sepsis. Sci Rep 8:12493
Long, Chandler A; Timmins, Lucas H; Koutakis, Panagiotis et al. (2017) An endovascular model of ischemic myopathy from peripheral arterial disease. J Vasc Surg 66:891-901
Brewster, Luke; Robinson, Scott; Wang, Ruoya et al. (2017) Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia. J Vasc Surg 65:826-838.e1
Ramos, Christopher R; Brewster, Luke P (2017) Advances, Pauses, and Future Opportunity for the Prevention of Venous Thromboembolism in the Trauma Population. JAMA Surg 152:41
Prologo, J David; Gilliland, Charles A; Miller, Michael et al. (2017) Percutaneous Image-Guided Cryoablation for the Treatment of Phantom Limb Pain in Amputees: A Pilot Study. J Vasc Interv Radiol 28:24-34.e4
Kim, Chan Woo; Pokutta-Paskaleva, Anastassia; Kumar, Sandeep et al. (2017) Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1. Circulation 136:1217-1232

Showing the most recent 10 out of 23 publications